Infertility · Ovulation Induction

Optimization of conception with intercourse for women with infertility

Boedeker D, Neumann B, Vest A, Hill MJ, Stanford JB, Johnstone EB

Published June 2026 Fertility and sterility
DOI 10.1016/j.fertnstert.2026.04.002 PMID 41966349

Abstract

This narrative review examines the evidence for medical optimization of inflammatory conditions, vitamin deficiencies, endocrine disorders, immune dysregulation, oligo-ovulation, and luteal phase factors to improve fertility outcomes in women attempting to conceive through natural or timed intercourse. Overall, there is a paucity of data with respect to these categories among patients pursuing timed intercourse, precluding our ability to draw strong recommendations. However, there is strong evidence supporting treatment of endocrine disorders, specifically overt thyroid dysfunction and hyperprolactinemia, as well as oligo-ovulation. Conversely, treatment of subclinical hypothyroidism is not recommended. The current data are insufficient to support empiric use of antiinflammatory medications, corticosteroids, thyroid hormones, or vitamins or supplements to improve chances of pregnancy in a general infertility population.

Topics

By this author

Related research

Infertility › Ovulation Induction › Clomiphene Citrate · Therapeutics › Metabolic and Endocrine Agents › Thyroid Replacement · Reproductive Endocrinology › Thyroid and Metabolic Function › Thyroid Disorders
David Boedeker, Brooke Neumann, Adriana Vest, Micah J Hill, Joseph B Stanford, Erica B Johnstone
Dave Boedeker, D Boedeker, B Neumann, A Vest, M Hill, Joe Stanford, Joey Stanford, J Stanford, E Johnstone
PMID 41966349 41966349 DOI 10.1016/j.fertnstert.2026.04.002 10.1016/j.fertnstert.2026.04.002 Boedeker et al. 2026, Boedeker 2026